Infant 25% DEXTROSE Injection — Class I drug recall D-0862-2017
Ongoing recall by Hospira Inc., reported 2017-05-31, distributed nationwide. Presence of Particulate Matter: human hair found within an internal sample syringe.
| Recall number | D-0862-2017 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2017-04-21 |
| Classified | 2017-05-24 |
| Reported by FDA | 2017-05-31 |
| Distributed | Nationwide (US) |
| Quantity | 71,550 syringes |
| Reason classes | specification failure |
| NDC | 00409-1775, 00409-1775-10, 00409-1775-40 |
| Expiration dates | 2017-10-01 |
Product
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10
Reason for recall
Presence of Particulate Matter: human hair found within an internal sample syringe.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0862-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.